Is XBiotech Inc. overvalued?

XBiotech Inc. (XBIT) — key valuation metrics and fundamentals.

No verdict

Price

$2.30

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$70.1M

Dividend yield

106.0%

Return on equity

-26.1%

Sector

Healthcare

Fair value compares XBIT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks